SIGACHI logo

Sigachi Industries Limited

SIGACHI·NSE·
₹27.43▼ -0.26 (-0.94%)
Market Cap1051.97 Cr
PE Ratio54.50
Volume6,92,808
Day High - Low27.68 - 26.50
52W High-Low40.80 - 16.65

Sigachi Industries Limited (SIGACHI): company summary

The company's business has deteriorated, with annual net profit swinging from a profit of ₹70 crore to a loss of ₹83 crore.

Sigachi Industries Limited (SIGACHI) is a micro-cap Healthcare company valued at ₹1,052 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Sigachi Industries Limited last traded at ₹27.43, modestly down 0.94% on the day.
Recent developments
On 2026-08-07, the company informed the Exchange about a Board Meeting scheduled for 13-Aug-2026 to consider and approve the unaudited financial results for the quarter ending 2026-06-30.
Financial performance
The company's business has deteriorated, with annual net profit swinging from a profit of ₹70 crore to a loss of ₹83 crore. The latest quarter showed a turnaround, with net profit turning from a loss of ₹101 crore to a profit of ₹8 crore, but revenue fell 5.4% year-on-year to ₹121 crore.
Valuation multiples
The stock trades at 54.5 times earnings, a premium to the Healthcare median of 32.0, 2.76 times book value. It yields 0.3%.
Things to watch
The company reported a net loss of ₹83 crore in its latest financial year, with net profit margin falling to -17.3% from 14.3% the prior year. The latest quarter net profit swung from a loss to a profit, but revenue declined year-on-year, and the stock is 30.6% below its 52-week high.
Where it stands
Sigachi Industries Ltd ended the latest quarter with a net profit of ₹8 crore, but the company reported a net loss of ₹83 crore for the latest financial year. The stock is 30.6% below its 52-week high, and the net profit margin has dropped significantly to -17.3%.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
4.4/10
Weak
Fair Value
Sign in to see
ROE
-15.67%
Weak
P/E
54.50x
Expensive
Debt / Equity
0.31
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day₹26.50
₹27.68
52W₹16.65
₹40.80
DocStoX take

Supported by growth (7.5), but held back by quality (2.0). Growth looks strong at 7.5, but that is offset by quality at 2.0 and valuation at 2.7. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.4
/10
Weak
Quality
Weak
ROE -15.7%
Valuation
Expensive
P/E 54.5×
Growth
Strong
Revenue +19.9% 5Y CAGR
Risk
Moderate
D/E 0.31
Momentum
Soft
45% of 52-week range

At a glance

Market Cap
₹1,052 Cr
52W High / Low
₹41 / ₹17
Dividend Yield
0.27%
Promoter Holding
36.69%
EPS (TTM)
₹0.50
Book Value
₹13.65

Key highlights

  • Revenue compounding 20% a year
  • Quality is weak (2.0/10)
1 Positive1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Sigachi Industries Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.